NCT07270081

Brief Summary

This is a prospective, randomized, controlled clinical trial designed to evaluate whether follicular flushing increases the number of cumulus-oocyte complexes (COCs) retrieved compared to single aspiration in patients with poor ovarian response belonging to Poseidon groups 3 and 4. A total of 40 patients with poor ovarian response belonging to Poseidon groups 3 and 4 will be included. In each patient, one ovary will be randomized to the study technique (follicular flushing), and the other ovary will be randomized to the control technique (single aspiration).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 8, 2025

Completed
24 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

November 17, 2025

Last Update Submit

April 13, 2026

Conditions

Keywords

Follicular flushingPoseidon 3 and 4Poor responderlow ovarian reserve

Outcome Measures

Primary Outcomes (1)

  • number of cumulus-oocyte complexes

    number of cumulus-oocyte complexes (COCs) retrieved after each aspiration

    During the egg retrieval

Secondary Outcomes (4)

  • Oocyte recovery rate

    day of the egg retrieval

  • Fertilization rate

    1 day after the egg retrieval

  • Empty follicle rate

    day of the egg retrieval

  • Procedure time

    In seconds from needle insertion to its withdrawal for each ovary

Study Arms (2)

Single Aspiration Arm

ACTIVE COMPARATOR

Oocytes will be retrieved from one ovary using single follicular aspiration

Procedure: follicular aspiration

Follicular Flushing Arm

EXPERIMENTAL

Oocytes will be retrieved from the contralateral ovary using follicular flushing, with up to three flushes per follicle if no cumulus-oocyte complex is obtained initially

Procedure: follicular flushing

Interventions

Follicles will be aspirated using 17G needles of the same gauge in both groups. For follicular flushing, the same type of needle used for single aspiration (Cook) will be employed. To eliminate dead space, the needle will be prefilled with flushing medium before starting the procedure. Aspiration pressure will be maintained at 190 mmHg during oocyte retrieval. In the follicular flushing group, if no cumulus-oocyte complex (COC) is recovered during the initial aspiration, follicular flushing will be performed until a COC is obtained, up to a maximum of three times. After three flushes, if no COC is retrieved, the procedure will be completed by rinsing with flushing medium to minimize the possibility of oocyte retention within the needle.

Follicular Flushing Arm

In the single aspiration group, after aspirating all follicles, the needle will be rinsed with flushing medium to prevent the possibility of oocyte retention within the needle.

Single Aspiration Arm

Eligibility Criteria

AgeUp to 43 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pacientes con baja respuesta ovárica grupos POSEIDON 3 y 4 (\< 35 años y RFA \<5 y/o AMH \< 1.2 ng/ml o \> 35 años≥ 35 años y RFA \<5 o AMH \<1.2 ng/mL respectivamente)
  • Pacientes menores o igual a 43 años.
  • Índice de Masa Corporal (IMC) de 18-35 kg/m2
  • Estimulación ovárica para ICSI
  • Presencia y accesibilidad de ambos ovarios.
  • Ausencia de patología ovárica
  • Cuando se cumplan los criterios de desencadenamiento para la maduración final del ovocito, cada ovario debe contener al menos un folículo mayor o igual a 14 mm.
  • Haber dado su consentimiento por escrito.

You may not qualify if:

  • Presence of a single ovary.
  • Presence of ovarian pathology.
  • Use of conventional IVF as the fertilization method.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Bernabeu

Alicante, Alicante, 03016, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Each participant will serve as her own control. One ovary will be randomized to single aspiration and the contralateral ovary to follicular flushing.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

November 17, 2025

First Posted

December 8, 2025

Study Start

January 1, 2026

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

April 14, 2026

Record last verified: 2026-04

Locations